A case of generalized morphea with a high titer of anti-Borrelia burgdorferi antibodies

Journal of Dermatology

Volumn 26, Issue 12, 1999, Pages 821-824

  Nakashima, Tomoko ^a   Maeda, Manabu ^d   Hayashi, Takao ^b   Kitamura, Ken ^c  

^a Department of Dermatology ^*  (Japan)

^b Internal Medicine   (Japan)

^c Kumiai Hospital   (Japan)

^d GIFU PREFECTURAL GIFU HOSPITAL   (Japan)

Author keywords

Anti Borrelia burgdorferi antibodies; Generalized morphea

Indexed keywords

ANTIALLERGIC AGENT; ANTIINFECTIVE AGENT; BACTERIUM ANTIBODY; CORTICOSTEROID; PREDNISOLONE; TETRACYCLINE;

AGED; ARTICLE; BORRELIA BURGDORFERI; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DISEASE COURSE; HUMAN; HUMAN TISSUE; MALE; MORPHEA; PRURITUS; SCLERODERMA; SKIN BIOPSY; TREATMENT OUTCOME;

EID: 0033389598     PISSN: 03852407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1346-8138.1999.tb02100.x     Document Type: Article

References (10)

1. Fujiwara H, Fujiwara K, Hashimoto K, et al: Detection of Borrelia burgdorferi DNA (B garinii or B afzelii) in morphea and lichen sclerosus et atrophicus tissues of German and Japanese but not of US patients, Arch Dermatol, 133: 41-44, 1997.
2. Aberer E, Stanek G, Ertl M, Neumann R: Evidence for spirochetal origin of circumscribed scleroderma (morphea), Acta Derm Venereol, 67: 225-231, 1987.
3. Abele DC, Anders KH: The many faces and phases of borreliosis II, J Am Acad Dermatol, 23: 401-410, 1990.
4. DeVito JR, Merogi AJ, Vo T, et al: Role of Borrelia burgdorferi in the pathogenesis of morphea/scleroderma and lichen sclerosus et atrophicus: A PCR study of thirty-five cases, J Cutan Pathol, 23: 350-358, 1996.
5. Buechner SA, Lautenschlager S, Itin P, Bircher A, Erb P: Lymphoproliferative responses to Borrelia burgdorferi in patients with erythema migrans, acrodermatitis chronica atrophicans, lymphadenosis benigna cutis, and morphea, Arch Dermatol, 131: 673-677, 1995.
6. Halkier-Smgensen L, Kragballe K, Hansen K: Antibodies to the Borrelia burgdorferi flagellum in patients with scleroderma, granuloma annulare and porphyria cutanea tarda, Acta Derm Venereol, 69: 116-119, 1989.
7. Schempp C, Bocklage H, Lange R, Kolmel HW, Orfanos CE, Gollnick H: Further evidence for Borrelia burgdorferi infection in morphea and lichen sclerosus et atrophicus confirmed by DNA amplification, J Invest Dermatol, 100: 717-720, 1993.
8. Aberer E, Klade H: Cutaneous manifestations of Lyme borreliosis, Infection, 19: 284-286, 1991.
9. Ishikawa H: Revised diagnostic criteria for progressive systemic sclerosis, Ryumachi, 24: 198-203, 1984.
10. Yamakage A, Ishikawa H: Generalized morphealike scleroderma occuring in people exposed to organic solvents, Dermatologica, 165: 186-193, 1982.